BS
Biotechnologies Assets S.A.
BST.MC · BME
0.22 € +0.00% (+0.00 €)
1M +1.84%
Market Cap 16.8M €
P/E Ratio -
Div. Yield -
ROE 29.69%
Piotroski F-Score Moderate
4/9Valuation
23 /100
Expensive P/B 2.72x
EV/EBITDA 160.96x
P/S 5.43x
Growth
60 /100
Stable Book val. growth 15.35%
Rev. growth 5.75%
FCF growth N/A
Profitability
1 /100
Weak Op. margin 61.59%
Gross margin 16.57%
FCF margin 0.49%
Quality
3 /100
Poor ROA 14.13%
ROIC 21.65%
Asset turnover 0.23x
Debt
40 /100
Moderate Int. coverage -11.17x
Debt/Equity 0.28x
Net debt/EBITDA 11.74x
Stability
3 /100
Unstable EPS volatility 225.27%
Beta 1.82x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BST.MC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Manuel Lopez Nieto
Employees
26
Headquarters
Cádiz